Table IV.
Comparison of rates of bacteraemia per 1000 intensive care-adjusted patient-days before and during the pandemic
| Blood isolate species | Pre-pandemic |
COVID-19 patients, Apr 2020–Jan 2021 |
||||
|---|---|---|---|---|---|---|
| Apr 2019–Mar 2020 (10,791 patient-days) |
Apr–Aug 2020 (2372 patient-days) |
Sep 2020–Jan 2021 (3008 patient-days) |
||||
| No. of patients | BSIs per 1000 patient-days | No. of patients | BSIs per 1000 patient-days | No. of patients | BSIs per 1000 patient-days | |
| Total | 84 | 7.78 | 43 | 18.12 | 76 | 25.27 |
| Coagulase-negative staphylococci | 57 | 5.28 | 26 | 10.96 | 42 | 13.97 |
| Candida albicans | 2 | 0.18 | 2 | 0.84 | 2 | 0.66 |
| Enterobacter cloacae | 2 | 0.18 | 0 | 0 | 1 | 0.33 |
| Enterococcus faecium | 16 | 1.48 | 7 | 2.95 | 1 | 0.33 |
| Escherichia coli | 26 | 2.41 | 2 | 0.84 | 2 | 0.66 |
| Klebsiella pneumoniae | 9 | 0.83 | 3 | 1.26 | 3 | 1.00 |
| Pseudomonas aeruginosa | 8 | 0.74 | 3 | 1.26 | 8 | 2.66 |
| Staphylococcus aureus | 8 | 0.74 | 0 | 0 | 8 | 3.37 |
BSI, bloodstream infection.